Pay in 4 interest-free payments of $5.12 Learn more
Ships within 48 hours · Estimated delivery Aug 27 - Sep 1
Before discharge, the appropriate indication for the use of Tirzepatide was explained to the patient and she was counselled about the adverse effects as well as the need for appropriate monitoring of weight, dose adjustment, and side-effects by a health care professional
announced that the FDA has approved WEGOVY as the first GLP-1 receptor agonist for adults with Metabolic Dysfunction-associated Steatohepatitis (MASH) who have moderate to advanced fibrosis, excluding In August 2025, Novo Nordisk cirrhosis , in combination with diet and exercise
The arrival of more approved generics is expected to drive prices lower and weaken the control that Novo Nordisk and Eli Lilly have exercised over the GLP-1 market
However, Mounjaro targets both GLP-1 and GIP receptors, making it a dual-action medication that may offer greater appetite suppression and improved metabolism for some patients
US$ 27.72
US$ 26.69
US$ 28.24
